This study shows that the median MACE incidence about patients with HFpEF at 17 months of follow-up is 17.12%, which is in general agreement with previous reports.[11,12] Patients in the adverse group have an increase in age, incidence of myocardial infarction, and elevated plasma BNP levels before admission. Here, NPPB is linked to myocardial infarction.